ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Robotics & Remote Systems
The Mission of the Robotics and Remote Systems Division is to promote the development and application of immersive simulation, robotics, and remote systems for hazardous environments for the purpose of reducing hazardous exposure to individuals, reducing environmental hazards and reducing the cost of performing work.
2020 ANS Virtual Winter Meeting
November 16–19, 2020
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Latest Journal Issues
Nuclear Science and Engineering
Fusion Science and Technology
Missouri S&T’s nuclear engineering program gains department status
Missouri S&T’s pool-type nuclear reactor. Photo: Sam O’Keefe/Missouri S&T
Sixty years ago, the Missouri University of Science and Technology (Missouri S&T), then known as the University of Missouri at Rolla, was one of the first U.S. institutions to offer a nuclear engineering degree. Now, decades after it was offered as an option within metallurgical engineering, Missouri S&T’s nuclear program has attained new status as the Nuclear Engineering and Radiation Science Department, the university announced on October 20.
Technical Session|Panel|Sponsored by IRD
Monday, November 16, 2020|12:00–2:10PM (1:00–3:10PM EST)
The session will be available to join at 11:30AM (12:30PM EST).
Lin-Wen Hu (MIT)
James Bowen (PNNL)
Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. For example, Tc-99m (decay product of Mo-99) is used in more than 80% of nuclear medicine diagnostic procedures. I-131 is widely used to treat thyroid cancer and applications of Lu-177 have increased in recent years for targeted therapy. This panel session will feature the following speakers to discuss the advancement and status of domestic production and applications of medical isotopes:
1) Peter J. Karcz: NNSA’s Mo-99 Program: Accelerating Reliable, Non-HEU Mo-99 Production Capabilities in the U.S.,
2) Greg Piefer: Progress at SHINE Medical in Commercializing Mo-99 and Lu-177 for Diagnostic and Therapeutic Applications,
3) Ira Goldman: Achieving Security of Supply of Medical Radioisotopes,
4) Les Foyto: MURR’s Role in Supplying Isotopes for Research and Patient Care, and
5) Jon Neuhoff: DOE Production of Radioisotopes for Medical Research, Diagnosis, and Treatment
To join the conversation, you must be logged in and registered for the meeting.
Register NowLog In